As of Mar 16
| +0.35 / +0.53%|
The 21 analysts offering 12-month price forecasts for Bristol-Myers Squibb Co have a median target of 64.00, with a high estimate of 75.00 and a low estimate of 50.00. The median estimate represents a -3.90% decrease from the last price of 66.60.
The current consensus among 24 polled investment analysts is to Hold stock in Bristol-Myers Squibb Co. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.